Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes

Microcirculation

Volumn 16, Issue 2, 2009, Pages 193-206

  Clements, Richard T ^a   Sodha, Neel R ^a   Feng, Jun ^a   Boodhwani, Munir ^a   Liu, Yuhong ^a   Mieno, Shigetoshi ^a   Khabbaz, Kamal R ^a   Bianchi, Cesario ^a   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coronary circulation; Diabetes; Myosin light chain; Vascular smooth muscle; Vasodilation

Indexed keywords

ALLOXAN; GUANYLATE CYCLASE; INSULIN; MYOSIN LIGHT CHAIN; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENDOTHELIUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SWINE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ALLOXAN; ANIMALS; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MICROVESSELS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; SWINE; SWINE, MINIATURE; VASODILATION;

SUIDAE;

EID: 58449111875     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680802461950     Document Type: Article

References (48)

1. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. and Kaibuchi, K. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem, 271, pp. 20246-20249.
2. 2 consumption with hyperglycemia. Am J Physiol Endocrinol Metab, 279, pp. E868-E874.
3. Bender, SB and Klabunde, RE. (2007) Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and {alpha}1-adrenoceptor-mediated vasoconstriction in type 2 diabetes. Am J Physiol Heart Circ Physiol, 293, pp. H2281-H2288.
4. Boodhwani, M., Sodha, NR, Mieno, S., Xu, SH, Feng, J., Ramlawi, B., Clements, RT and Sellke, FW. (2007) Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation, 116, pp. I31-I37.
5. Britten, MB, Zeiher, AM and Schachinger, V. (1999) Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med, 245, pp. 315-327.
6. Brooks, BA, Franjic, B., Ban, CR, Swaraj, K., Yue, DK, Celermajer, DS and Twigg, SM. (2007) Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diab Obes Metab, 10, pp. 739-746.
7. Brooks, BA, McLennan, SV, Twigg, SM and Yue, DK. (2008) Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diab Vasc Dis Res, 5, pp. 30-35.
8. Browner, NC, Dey, NB, Bloch, KD and Lincoln, TM. (2004) Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem, 279, pp. 46631-46636.
9. Chakraphan, D., Sridulyakul, P., Thipakorn, B., Bunnag, S., Huxley, VH and Patumraj, S. (2005) Attenuation of endothelial dysfunction by exercise training in STZ-induced diabetic rats. Clin Hemorheol Microcirc, 32, pp. 217-226.
10. Chang, S., Hypolite, JA, DiSanto, ME, Changolkar, A., Wein, AJ and Chacko, S. (2006) Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol, 290, pp. F650-F656.
11. Clements, RT, Minnear, FL, Singer, HA, Keller, RS and Vincent, PA. (2005) RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability. Am J Physiol Lung Cell Mol Physiol, 288, pp. L294-L306.
12. Clements, RT, Sodha, NR, Feng, J., Mieno, S., Boodhwani, M., Ramlawi, B., Bianchi, C. and Sellke, FW. (2007) Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass. J Thorac Cardiovasc Surg, 134, pp. 1461-1470.
13. Clough, GF, Bennett, AR and Church, MK. (1998) Measurement of nitric oxide concentration in human skin in vivo using dermal microdialysis. Exp Physiol, 83, pp. 431-434.
14. Di Carli, MF, Janisse, J., Grunberger, G. and Ager, J. (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol, 41, pp. 1387-1393.
15. Gatenby, PA. (1991) The role of complement in the aetiopathogenesis of systemic lupus erythematosus. Autoimmunity, 11, pp. 61-66.
16. Goodfellow, J. (1997) Microvascular heart disease in diabetes mellitus. Diabetologia, 40, pp. S130-S133.
17. Heitzer, T., Krohn, K., Albers, S. and Meinertz, T. (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia, 43, pp. 1435-1438.
18. Hofmann, F. (2005) The biology of cyclic GMP-dependent protein kinases. J Biol Chem, 280, pp. 1-4.
19. Hsueh, WA and Quinones, MJ. (2003) Role of endothelial dysfunction in insulin resistance. Am J Cardiol, 92, pp. 10-17.
20. Johnstone, MT, Creager, SJ, Scales, KM, Cusco, JA, Lee, BK and Creager, MA. (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation, 88, pp. 2510-2516.
21. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A. and Kaibuchi, K. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) [see comments]. Science, 273, pp. 245-248.
22. Koltai, MZ, Hadhazy, P., Posa, I., Kocsis, E., Winkler, G., Rosen, P. and Pogatsa, G. (1997) Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res, 34, pp. 157-163.
23. Lee, JH and Ragolia, L. (2006) AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol, 291, pp. C1355-C1365.
24. Liu, S., Ma, X., Gong, M., Shi, L., Lincoln, T. and Wang, S. (2007) Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Rad Biol Med, 42, pp. 852-863.
25. McVeigh, GE, Brennan, GM, Johnston, GD, McDermott, BJ, McGrath, LT, Henry, WR, Andrews, JW and Hayes, JR. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 35, pp. 771-776.
26. Milsom, AB, Jones, CJ, Goodfellow, J., Frenneaux, MP, Peters, JR and James, PE. (2002) Abnormal metabolic fate of nitric oxide in type I diabetes mellitus. Diabetologia, 45, pp. 1515-1522.
27. Miura, H., Wachtel, RE, Loberiza Jr, FR, Saito, T., Miura, M., Nicolosi, AC and Gutterman, DD. (2003) Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res, 92, pp. 151-158.
28. Muniyappa, R., Montagnani, M., Koh, KK and Quon, MJ. (2007) Cardiovascular actions of insulin. Endocr Rev, 28, pp. 463-491.
29. Munzel, T., Daiber, A., Ullrich, V. and Mulsch, A. (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol, 25, pp. 1551-1557.
30. Nahser Jr, PJ, Brown, RE, Oskarsson, H., Winniford, MD and Rossen, JD. (1995) Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation, 91, pp. 635-640.
31. Nakamura, M., Ichikawa, K., Ito, M., Yamamori, B., Okinaka, T., Isaka, N., Yoshida, Y., Fujita, S. and Nakano, T. (1999) Effects of the phosphorylation of myosin phosphatase by cyclic GMP-dependent protein kinase. Cell Sign, 11, pp. 671-676.
32. Natali, A., Toschi, E., Baldeweg, S., Casolaro, A., Baldi, S., Sironi, AM, Yudkin, JS and Ferrannini, E. (2005) Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J, 26, pp. 464-471.
33. Nitenberg, A., Valensi, P., Sachs, R., Dali, M., Aptecar, E. and Attali, JR. (1993) Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 42, pp. 1017-1025.
34. Noda, M., Yasuda-Fukazawa, C., Moriishi, K., Kato, T., Okuda, T., Kurokawa, K. and Takuwa, Y. (1995) Involvement of rho in GTPgammaS-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: Inhibition of phosphatase activity. FEBS Lett, 367, pp. 246-250.
35. Pfitzer, G. (2001) Invited review: Regulation of myosin phosphorylation in smooth muscle. J Appl Physiol, 91, pp. 497-503.
36. Prior, JO, Quinones, MJ, Hernandez-Pampaloni, M., Facta, AD, Schindler, TH, Sayre, JW, Hsueh, WA and Schelbert, HR. (2005) Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation, 111, pp. 2291-2298.
37. Sanz, E., Fernandez, N., Monge, L., Martinez, MA, Climent, B., Dieguez, G. and Garcia-Villalon, AL. (2003) Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: Gender and regional differences. Life Sci, 72, pp. 1537-1547.
38. Schachinger, V., Britten, MB and Zeiher, AM. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101, pp. 1899-1906.
39. Simonsen, U., Wadsworth, RM, Buus, NH and Mulvany, MJ. (1999) In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J Physiol, 516, pp. 271-282.
40. Su, X., Changolkar, A., Chacko, S. and Moreland, RS. (2004) Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylation. Am. J Physiol Renal Physiol, 287, pp. F690-F699.
41. Sundell, J., Laine, H., Nuutila, P., Ronnemaa, T., Luotolahti, M., Raitakari, O. and Knuuti, J. (2002) The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated type I diabetes. Diabetologia, 45, pp. 775-782.
42. Szerafin, T., Erdei, N., Fulop, T., Pasztor, ET, Edes, I., Koller, A. and Bagi, Z. (2006) Increased cyclo-oxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res, 99, pp. e12-e317.
43. Tofukuji, M., Metais, C., Li, J., Hariawala, MD, Franklin, A., Vassileva, C., Li, J., Simons, M. and Sellke, FW. (1998) Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation. Circulation, 98, pp. II197-II204.
44. Xie, Z., Su, W., Guo, Z., Pang, H., Post, SR and Gong, MC. (2006) Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res, 69, pp. 491-501.
45. Watts, GF, O'Brien, SF, Silvester, W. and Millar, JA. (1996) Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia. Clin Sci (Lond), 91, pp. 567-573.
46. Williams, SB, Cusco, JA, Roddy, MA, Johnstone, MT and Creager, MA. (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol, 27, pp. 567-574.
47. Wooldridge, AA, MacDonald, JA, Erdodi, F., Ma, C., Borman, MA, Hartshorne, DJ and Haystead, TA. (2004) Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J Biol Chem, 279, pp. 34496-34504.
48. Zhou, W., Wang, XL, Lamping, KG and Lee, HC. (2006) Inhibition of protein kinase Cbeta protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries. J Pharmacol Exp Ther, 319, pp. 199-207.